5,722 Shares in Cardinal Health, Inc. $CAH Bought by Ausdal Financial Partners Inc.

Key Points

• Ausdal Financial Partners bought 5,722 shares of Cardinal Health in the second quarter, worth approximately $1.36 million. Institutional investors collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, exceeding estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company guided to fiscal 2027 EPS of $12.40–$12.60.
• Insiders have sold 210,271 shares worth roughly $49.6 million over the past 90 days, including significant sales by the CEO and an insider. Despite the selling, analysts maintain a “Moderate Buy” consensus with an average price target of $266.56.

Ausdal Financial Partners Inc. acquired a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,722 shares of the company's stock, valued at approximately $1,359,000.

Other hedge funds have also recently made changes to their positions in the company. Investors Research Corp bought a new stake in Cardinal Health during the 2nd quarter valued at approximately $29,000. University of Texas Texas AM Investment Management Co. bought a new position in shares of Cardinal Health in the 4th quarter worth approximately $26,000. Allied Private Wealth LLC purchased a new position in shares of Cardinal Health in the 2nd quarter valued at approximately $30,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health in the 4th quarter valued at approximately $27,000. Finally, Indiana Trust & Investment Management Co bought a new stake in shares of Cardinal Health during the first quarter valued at approximately $29,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cardinal Health

In related news, insider Michelle D. Greene sold 11,650 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total value of $2,746,138.00. Following the transaction, the insider directly owned 10,330 shares of the company's stock, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen M. Mason sold 35,000 shares of the company's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the transaction, the chief executive officer owned 18,061 shares of the company's stock, valued at $4,269,620.40. The trade was a 65.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $238.61 on Thursday. The stock has a market capitalization of $55.50 billion, a PE ratio of 33.00, a price-to-earnings-growth ratio of 1.43 and a beta of 0.49. Cardinal Health, Inc. has a 52-week low of $145.87 and a 52-week high of $258.30. The company has a 50-day simple moving average of $232.59 and a two-hundred day simple moving average of $218.25.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is currently 28.49%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Royal Bank Of Canada initiated coverage on shares of Cardinal Health in a report on Wednesday, August 19th. They set an "outperform" rating and a $276.00 target price on the stock. Weiss Ratings lowered shares of Cardinal Health from a "buy (b+)" rating to a "buy (b)" rating in a research note on Wednesday, August 19th. Mizuho lifted their price target on shares of Cardinal Health from $240.00 to $250.00 and gave the company an "outperform" rating in a research report on Wednesday, August 12th. Robert W. Baird boosted their price objective on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 12th. Finally, Evercore restated an "outperform" rating and issued a $270.00 price objective on shares of Cardinal Health in a report on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source